Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.18 | 8e-08 |
mRNA | AZD0530 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-07 |
mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-07 |
mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.17 | 6e-07 |
mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.16 | 1e-06 |
mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.17 | 2e-06 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.17 | 5e-06 |
mRNA | niclosamide | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-06 |
mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.14 | 2e-05 |
mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-05 |